Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Fenghuang Zhan

Concepts (597)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
140
2026
3082
10.010
Why?
Gene Expression Regulation, Neoplastic
53
2025
868
3.080
Why?
Drug Resistance, Neoplasm
25
2020
350
2.830
Why?
Plasma Cells
24
2025
234
2.820
Why?
Gene Expression Profiling
44
2025
1112
2.700
Why?
Monoclonal Gammopathy of Undetermined Significance
9
2025
123
2.580
Why?
Cell Proliferation
25
2022
1031
2.050
Why?
Antineoplastic Agents
29
2020
1232
1.950
Why?
Cell Line, Tumor
46
2025
1470
1.820
Why?
Neoplastic Stem Cells
7
2020
90
1.560
Why?
Pyrazines
19
2023
188
1.460
Why?
Disease Progression
19
2025
880
1.450
Why?
Humans
163
2026
53230
1.350
Why?
Mice
48
2025
5982
1.340
Why?
Paraproteinemias
9
2024
72
1.330
Why?
Prognosis
40
2026
2118
1.310
Why?
Lymphoma, B-Cell
5
2021
60
1.310
Why?
Neoplasm Proteins
8
2026
330
1.300
Why?
Apoptosis
18
2025
1139
1.300
Why?
Boronic Acids
17
2014
180
1.260
Why?
Bone Resorption
6
2024
304
1.260
Why?
Animals
59
2025
13526
1.160
Why?
Tumor Microenvironment
6
2024
274
1.120
Why?
Osteolysis
4
2022
74
1.030
Why?
B-Lymphocytes
8
2021
178
0.990
Why?
Cell Cycle Proteins
4
2023
170
0.950
Why?
T-Lymphocytes
8
2024
321
0.930
Why?
Hematopoietic Stem Cell Transplantation
6
2024
610
0.910
Why?
Ubiquitination
3
2021
58
0.860
Why?
Proteasome Inhibitors
7
2020
104
0.850
Why?
Signal Transduction
21
2023
1748
0.800
Why?
Proteasome Endopeptidase Complex
4
2018
141
0.750
Why?
MicroRNAs
7
2022
397
0.750
Why?
Antigens, CD
8
2024
217
0.710
Why?
Neoplasms
3
2024
1334
0.680
Why?
Iron
3
2017
130
0.660
Why?
Ascorbic Acid
2
2017
26
0.650
Why?
Carrier Proteins
3
2017
315
0.610
Why?
CDC2-CDC28 Kinases
3
2015
11
0.610
Why?
Cation Transport Proteins
2
2019
26
0.600
Why?
Chromosome Aberrations
7
2025
297
0.600
Why?
Up-Regulation
6
2020
456
0.580
Why?
Ubiquitins
2
2016
18
0.580
Why?
Cyclin-Dependent Kinases
2
2010
26
0.580
Why?
Mice, Inbred NOD
5
2020
90
0.570
Why?
Oligonucleotide Array Sequence Analysis
19
2014
412
0.570
Why?
Glycolysis
3
2022
76
0.570
Why?
Waldenstrom Macroglobulinemia
1
2018
38
0.570
Why?
Cell Survival
11
2020
600
0.550
Why?
Proto-Oncogene Proteins c-akt
5
2023
171
0.540
Why?
Cell Differentiation
9
2023
681
0.540
Why?
Pyrimidines
3
2015
205
0.530
Why?
STAT3 Transcription Factor
4
2016
89
0.530
Why?
Lymphoma, Large B-Cell, Diffuse
3
2026
110
0.520
Why?
Killer Cells, Natural
5
2024
113
0.520
Why?
Pyruvate Kinase
1
2017
7
0.520
Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
1043
0.510
Why?
Female
48
2026
28782
0.500
Why?
RNA Splicing
1
2017
43
0.500
Why?
Male
38
2026
27435
0.490
Why?
Protein-Tyrosine Kinases
2
2015
87
0.480
Why?
Down-Regulation
9
2019
344
0.470
Why?
Cyclopentanes
1
2015
12
0.460
Why?
Transplantation, Autologous
5
2024
488
0.460
Why?
Thalidomide
10
2023
378
0.460
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2015
68
0.460
Why?
Aldehyde Dehydrogenase
1
2014
24
0.440
Why?
Osteoclasts
7
2023
428
0.440
Why?
Dexamethasone
7
2024
429
0.440
Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2020
17
0.430
Why?
Flow Cytometry
8
2018
400
0.410
Why?
Hematologic Neoplasms
1
2015
101
0.410
Why?
Models, Biological
5
2018
737
0.410
Why?
Receptors, Retinoic Acid
2
2013
22
0.400
Why?
Cystatin M
2
2024
17
0.400
Why?
Aged
27
2026
10429
0.400
Why?
RNA, Messenger
13
2021
1133
0.390
Why?
B-Cell Maturation Antigen
2
2024
101
0.380
Why?
Antigens, Neoplasm
6
2014
146
0.380
Why?
Mice, Transgenic
7
2021
561
0.380
Why?
Glucuronidase
4
2018
47
0.370
Why?
Predictive Value of Tests
5
2016
934
0.360
Why?
Syndecan-1
6
2017
73
0.340
Why?
Antibodies, Bispecific
2
2023
108
0.340
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
7
0.340
Why?
Arsenicals
1
2010
15
0.340
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
18
0.340
Why?
Middle Aged
26
2026
13419
0.330
Why?
Oxides
1
2010
21
0.330
Why?
Reverse Transcriptase Polymerase Chain Reaction
12
2015
579
0.330
Why?
Janus Kinase 1
1
2010
16
0.320
Why?
Proto-Oncogene Proteins c-jun
2
2009
76
0.320
Why?
MAP Kinase Kinase 1
1
2010
22
0.320
Why?
DNA-Binding Proteins
4
2021
423
0.320
Why?
Immunotherapy, Adoptive
2
2024
163
0.320
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
84
0.310
Why?
Macrophages
3
2026
380
0.310
Why?
Early Growth Response Protein 1
1
2009
34
0.310
Why?
Transcription Factors
6
2022
571
0.300
Why?
Tretinoin
1
2009
53
0.290
Why?
Oligopeptides
3
2015
94
0.290
Why?
Xenograft Model Antitumor Assays
7
2019
228
0.290
Why?
Membrane Proteins
4
2018
333
0.290
Why?
Aged, 80 and over
9
2026
3494
0.290
Why?
Osteogenesis
5
2023
374
0.280
Why?
Adult
23
2026
14534
0.280
Why?
NF-kappa B
3
2018
327
0.280
Why?
Retrospective Studies
9
2026
6819
0.280
Why?
Tumor Cells, Cultured
6
2020
441
0.280
Why?
Genes, Neoplasm
1
2008
31
0.280
Why?
Antibodies
3
2024
147
0.270
Why?
Microarray Analysis
3
2018
69
0.270
Why?
Chromosomes, Human, Pair 1
4
2023
95
0.260
Why?
Oxidative Stress
5
2017
819
0.260
Why?
Immunologic Factors
5
2015
117
0.260
Why?
Interleukin-6
3
2019
272
0.260
Why?
S-Phase Kinase-Associated Proteins
1
2007
2
0.260
Why?
Risk Factors
12
2026
4017
0.260
Why?
Neoplasms, Plasma Cell
2
2023
35
0.260
Why?
Tumor Suppressor Protein p53
2
2008
228
0.260
Why?
Small Molecule Libraries
2
2019
66
0.260
Why?
Pyrazoles
2
2020
123
0.250
Why?
Phosphate-Binding Proteins
1
2026
8
0.240
Why?
Mice, SCID
9
2018
180
0.240
Why?
Cytomegalovirus
1
2026
42
0.240
Why?
CD8-Positive T-Lymphocytes
3
2024
145
0.230
Why?
Cytomegalovirus Infections
1
2026
49
0.230
Why?
Virus Activation
1
2026
49
0.230
Why?
Endopeptidase Clp
1
2025
3
0.230
Why?
Protein Kinase Inhibitors
3
2024
233
0.230
Why?
Genomics
2
2023
271
0.230
Why?
Intracellular Signaling Peptides and Proteins
1
2026
136
0.230
Why?
Enzyme Inhibitors
4
2019
371
0.220
Why?
Survival Rate
8
2020
949
0.220
Why?
Bone Diseases
4
2016
94
0.220
Why?
Bone Marrow
7
2024
359
0.220
Why?
Polycomb Repressive Complex 2
2
2021
48
0.220
Why?
ROC Curve
1
2025
246
0.220
Why?
Diffusion Magnetic Resonance Imaging
1
2025
133
0.220
Why?
Single-Cell Analysis
1
2025
72
0.210
Why?
Transcriptome
2
2025
367
0.210
Why?
Receptors, LDL
1
2024
73
0.210
Why?
TNF Receptor-Associated Factor 3
2
2022
13
0.210
Why?
Propionates
1
2024
23
0.210
Why?
Hydroxybenzoates
1
2024
25
0.210
Why?
Ferritins
1
2024
38
0.210
Why?
Myeloid Progenitor Cells
1
2023
15
0.210
Why?
Neoplasms, Second Primary
1
2024
75
0.200
Why?
X-Ray Microtomography
1
2024
80
0.200
Why?
Histocompatibility Antigens Class I
2
2015
47
0.200
Why?
Melphalan
3
2023
180
0.200
Why?
Bone Marrow Cells
4
2015
188
0.200
Why?
Antigens, CD19
3
2018
29
0.200
Why?
Cholesterol
1
2024
161
0.200
Why?
Proteolysis
4
2018
105
0.200
Why?
Positron-Emission Tomography
1
2025
298
0.200
Why?
Membrane Glycoproteins
6
2009
238
0.200
Why?
Cell Transformation, Neoplastic
1
2024
187
0.200
Why?
Genes, myc
3
2019
39
0.200
Why?
Intercellular Signaling Peptides and Proteins
4
2007
107
0.200
Why?
Lymphoma
1
2024
71
0.200
Why?
Proto-Oncogene Proteins c-myc
3
2025
55
0.200
Why?
Colonic Neoplasms
2
2022
162
0.200
Why?
Bone Diseases, Metabolic
1
2024
79
0.200
Why?
Homeostasis
1
2024
209
0.200
Why?
Cluster Analysis
5
2009
237
0.200
Why?
Gene Knockdown Techniques
3
2018
109
0.190
Why?
Phenols
1
2024
94
0.190
Why?
Bone and Bones
2
2021
501
0.190
Why?
Neutropenia
1
2023
113
0.190
Why?
NM23 Nucleoside Diphosphate Kinases
1
2022
4
0.190
Why?
Protein Binding
2
2018
670
0.190
Why?
Recurrence
7
2018
694
0.190
Why?
Periodontitis
1
2022
11
0.190
Why?
Antibodies, Monoclonal
3
2013
477
0.190
Why?
Randomized Controlled Trials as Topic
6
2016
630
0.190
Why?
Case-Control Studies
8
2020
1212
0.180
Why?
In Situ Hybridization, Fluorescence
5
2023
266
0.180
Why?
Reactive Oxygen Species
4
2017
421
0.180
Why?
Osteoporosis
1
2023
159
0.180
Why?
Protein Stability
2
2020
45
0.180
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
175
0.180
Why?
Kaplan-Meier Estimate
5
2016
487
0.180
Why?
Arthritis, Rheumatoid
1
2022
117
0.180
Why?
Heterogeneous-Nuclear Ribonucleoprotein Group A-B
1
2021
1
0.170
Why?
Nuclear Factor 90 Proteins
1
2021
1
0.170
Why?
RANK Ligand
1
2022
188
0.170
Why?
Gene Expression Regulation
3
2022
1003
0.170
Why?
Mitochondria
1
2025
446
0.170
Why?
Venous Thromboembolism
3
2011
78
0.170
Why?
Gene Expression
4
2017
618
0.170
Why?
Hippurates
1
2021
9
0.170
Why?
Cell Cycle
4
2010
237
0.170
Why?
Phenylpropionates
1
2021
14
0.170
Why?
Bone Neoplasms
2
2015
188
0.170
Why?
Ubiquitin-Protein Ligases
2
2020
140
0.170
Why?
Adaptor Proteins, Signal Transducing
1
2021
202
0.170
Why?
Protease Inhibitors
3
2011
59
0.160
Why?
Treatment Outcome
12
2020
5595
0.160
Why?
Antigens, CD20
2
2014
6
0.160
Why?
Neoplasm Metastasis
4
2015
237
0.160
Why?
Receptors, G-Protein-Coupled
1
2021
58
0.160
Why?
Cell Movement
2
2015
279
0.160
Why?
Evolution, Molecular
1
2021
97
0.160
Why?
Time Factors
8
2021
2991
0.160
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2015
59
0.160
Why?
Disease-Free Survival
7
2016
466
0.160
Why?
Practice Guidelines as Topic
1
2023
502
0.160
Why?
Chromosomal Instability
3
2021
16
0.160
Why?
Colorectal Neoplasms
2
2022
302
0.160
Why?
Cytotoxicity, Immunologic
4
2015
55
0.160
Why?
Clinical Trials as Topic
1
2022
466
0.160
Why?
Neoplasm Recurrence, Local
1
2024
647
0.160
Why?
Tumor Suppressor Proteins
2
2019
130
0.160
Why?
DNA, Single-Stranded
1
2020
88
0.150
Why?
NF-E2-Related Factor 2
1
2019
47
0.150
Why?
Oncogene Proteins
1
2019
19
0.150
Why?
Mitosis
3
2015
86
0.150
Why?
rab GTP-Binding Proteins
1
2019
23
0.150
Why?
Excitation Contraction Coupling
1
2018
3
0.150
Why?
Carcinoma, Neuroendocrine
1
2019
27
0.150
Why?
Transplantation, Heterologous
2
2017
78
0.150
Why?
Receptors, Interleukin-6
1
2018
22
0.150
Why?
Healthcare Disparities
1
2022
312
0.140
Why?
Neovascularization, Pathologic
3
2009
158
0.140
Why?
Drug Tolerance
1
2018
60
0.140
Why?
Adaptation, Physiological
2
2018
109
0.140
Why?
Blotting, Western
3
2015
587
0.140
Why?
Pyridines
1
2019
135
0.140
Why?
Myocardial Contraction
1
2018
109
0.140
Why?
Cardiomegaly
1
2018
55
0.140
Why?
Ventricular Remodeling
1
2018
66
0.140
Why?
Cell Nucleus
1
2018
187
0.140
Why?
Glucaric Acid
1
2017
2
0.140
Why?
Lung Neoplasms
1
2024
645
0.130
Why?
Drug Therapy, Combination
2
2017
405
0.130
Why?
Ferric Compounds
1
2017
16
0.130
Why?
beta Catenin
2
2015
107
0.130
Why?
Myocytes, Cardiac
1
2018
147
0.130
Why?
M Phase Cell Cycle Checkpoints
1
2017
5
0.130
Why?
Mice, Knockout
4
2023
910
0.130
Why?
Hydroxamic Acids
2
2014
38
0.130
Why?
Aerobiosis
1
2017
13
0.130
Why?
Microfilament Proteins
1
2017
44
0.130
Why?
Onium Compounds
1
2016
13
0.130
Why?
Calcium-Binding Proteins
1
2017
58
0.130
Why?
Deoxyglucose
1
2016
35
0.130
Why?
Thyroid Hormones
1
2017
23
0.130
Why?
Organophosphorus Compounds
1
2016
18
0.130
Why?
Histone Deacetylase Inhibitors
2
2014
60
0.130
Why?
Survival Analysis
6
2020
659
0.130
Why?
Pancreatic Neoplasms
1
2019
219
0.120
Why?
Inhibitor of Apoptosis Proteins
3
2015
21
0.120
Why?
Syndecans
3
2006
37
0.120
Why?
Gene Deletion
2
2008
279
0.120
Why?
RNA Interference
2
2015
181
0.120
Why?
Cell Death
1
2016
171
0.120
Why?
Ribosomal Proteins
1
2016
24
0.120
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2016
45
0.120
Why?
Proto-Oncogene Proteins
2
2009
150
0.120
Why?
Neoplasm Staging
4
2025
774
0.120
Why?
Proteoglycans
3
2006
86
0.120
Why?
Muscle Proteins
1
2018
350
0.120
Why?
Oncolytic Virotherapy
1
2015
28
0.120
Why?
Gene Dosage
2
2013
76
0.120
Why?
Cell Adhesion Molecules
1
2015
88
0.120
Why?
Calcium Channels
1
2015
38
0.110
Why?
Receptors, Transferrin
1
2015
16
0.110
Why?
Core Binding Factor Alpha 1 Subunit
1
2015
46
0.110
Why?
Polysaccharides
1
2015
57
0.110
Why?
Mitochondria, Heart
1
2015
39
0.110
Why?
Side-Population Cells
1
2015
3
0.110
Why?
Receptors, Cell Surface
1
2015
109
0.110
Why?
Serine Endopeptidases
2
2006
50
0.110
Why?
Lentivirus
1
2015
17
0.110
Why?
Retinal Dehydrogenase
1
2014
10
0.110
Why?
Patient Selection
2
2023
273
0.110
Why?
Adenine
1
2015
29
0.110
Why?
Transcription, Genetic
3
2018
374
0.110
Why?
Caspase 3
2
2022
92
0.110
Why?
Serum
1
2014
32
0.110
Why?
Cell Lineage
1
2014
90
0.110
Why?
Proto-Oncogene Proteins c-kit
1
2014
34
0.110
Why?
Translocation, Genetic
4
2021
266
0.110
Why?
Superoxide Dismutase
1
2014
122
0.110
Why?
Tumor Burden
3
2020
132
0.110
Why?
Piperidines
1
2015
98
0.110
Why?
Stress, Physiological
1
2015
184
0.110
Why?
Cyclins
3
2015
38
0.100
Why?
Alkaline Phosphatase
2
2011
92
0.100
Why?
HLA Antigens
1
2014
55
0.100
Why?
Glycoproteins
1
2014
121
0.100
Why?
Repressor Proteins
4
2015
149
0.100
Why?
11-beta-Hydroxysteroid Dehydrogenase Type 2
1
2013
12
0.100
Why?
Lactate Dehydrogenases
1
2013
1
0.100
Why?
Leukemia, Plasma Cell
1
2013
35
0.100
Why?
Genome, Human
2
2021
121
0.100
Why?
Phenotype
4
2009
803
0.100
Why?
Intercellular Adhesion Molecule-1
1
2013
59
0.100
Why?
Follow-Up Studies
5
2024
2318
0.100
Why?
Dose-Response Relationship, Drug
4
2020
1367
0.100
Why?
Leukemia
1
2013
67
0.100
Why?
Disease Models, Animal
4
2020
1517
0.100
Why?
Scavenger Receptors, Class A
1
2013
43
0.100
Why?
bcl-X Protein
1
2013
56
0.100
Why?
Heart
1
2015
350
0.100
Why?
Heat-Shock Proteins
1
2013
104
0.090
Why?
RNA, Small Interfering
2
2010
214
0.090
Why?
RNA, Neoplasm
3
2007
45
0.090
Why?
Forkhead Transcription Factors
2
2023
120
0.090
Why?
Clinical Trials, Phase III as Topic
2
2012
48
0.090
Why?
Drug Screening Assays, Antitumor
3
2020
136
0.090
Why?
Cysteine Proteinase Inhibitors
1
2011
21
0.090
Why?
Activated Protein C Resistance
1
2011
10
0.090
Why?
Factor V
1
2011
10
0.090
Why?
Protein Isoforms
2
2009
124
0.090
Why?
Acetylcysteine
1
2011
104
0.090
Why?
Glucocorticoids
1
2013
236
0.090
Why?
Interferon Regulatory Factor-1
1
2010
14
0.080
Why?
Cell Growth Processes
1
2010
24
0.080
Why?
HLA-A Antigens
2
2007
11
0.080
Why?
Cells, Cultured
6
2015
1569
0.080
Why?
Gene Silencing
2
2007
122
0.080
Why?
Alleles
2
2021
277
0.080
Why?
Mice, Inbred C57BL
3
2021
1925
0.080
Why?
Thrombosis
1
2012
250
0.080
Why?
Immunophenotyping
5
2010
118
0.080
Why?
K562 Cells
3
2016
42
0.080
Why?
Microtubule-Associated Proteins
1
2009
61
0.080
Why?
Epigenesis, Genetic
2
2023
412
0.080
Why?
Recombinant Proteins
1
2010
489
0.080
Why?
Bone Remodeling
1
2010
154
0.080
Why?
Chromosome Mapping
2
2006
145
0.070
Why?
HCT116 Cells
2
2020
31
0.070
Why?
Thromboembolism
1
2009
48
0.070
Why?
Mutation
3
2021
1337
0.070
Why?
Lymphocyte Subsets
1
2008
14
0.070
Why?
ras Proteins
2
2020
64
0.070
Why?
Angiogenesis Inhibitors
1
2009
186
0.070
Why?
Receptors, Immunologic
1
2008
36
0.070
Why?
Neoplasm Transplantation
2
2020
86
0.070
Why?
G2 Phase Cell Cycle Checkpoints
2
2020
9
0.070
Why?
Risk Assessment
3
2025
1368
0.070
Why?
Protein Tyrosine Phosphatases
1
2007
15
0.070
Why?
Breast Neoplasms
2
2007
1222
0.070
Why?
Adoptive Transfer
1
2007
29
0.070
Why?
Genes, abl
1
2007
2
0.070
Why?
Cross-Sectional Studies
2
2023
1723
0.070
Why?
HEK293 Cells
2
2019
235
0.070
Why?
Cancer Vaccines
1
2007
79
0.060
Why?
JNK Mitogen-Activated Protein Kinases
1
2007
71
0.060
Why?
Drug Evaluation, Preclinical
2
2021
142
0.060
Why?
Caspases
1
2007
101
0.060
Why?
Cyclin D
1
2006
18
0.060
Why?
Chromosome Banding
1
2006
24
0.060
Why?
Models, Genetic
1
2006
169
0.060
Why?
Proportional Hazards Models
2
2024
445
0.060
Why?
Palatine Tonsil
2
2003
11
0.060
Why?
DNA Damage
1
2008
309
0.060
Why?
Peptides
1
2007
234
0.060
Why?
Maf Transcription Factors, Large
1
2005
1
0.060
Why?
Gene Expression Regulation, Enzymologic
1
2007
180
0.060
Why?
Data Interpretation, Statistical
1
2006
169
0.060
Why?
Doxorubicin
2
2018
247
0.060
Why?
Protein Kinases
1
2005
72
0.060
Why?
Cyclin D1
1
2005
59
0.060
Why?
Antibody Formation
1
2005
49
0.060
Why?
Hydrogen Peroxide
2
2017
121
0.060
Why?
Protein Biosynthesis
2
2003
268
0.050
Why?
Neoplasm, Residual
1
2025
171
0.050
Why?
Base Sequence
3
2015
620
0.050
Why?
Papillomaviridae
1
2005
104
0.050
Why?
Cystadenocarcinoma, Serous
1
2004
73
0.050
Why?
Carcinoma, Papillary
1
2004
50
0.050
Why?
Transfection
2
2020
359
0.050
Why?
Mice, Inbred BALB C
2
2019
310
0.050
Why?
Drug Synergism
2
2014
147
0.050
Why?
Consensus
1
2025
206
0.050
Why?
Jurkat Cells
2
2014
29
0.050
Why?
Genetic Predisposition to Disease
1
2007
533
0.050
Why?
Extracellular Matrix Proteins
1
2004
69
0.050
Why?
Glucose
2
2016
361
0.050
Why?
Zebrafish Proteins
1
2003
25
0.050
Why?
Ovariectomy
1
2024
114
0.050
Why?
Adipogenesis
1
2024
54
0.050
Why?
Steroids
1
2024
61
0.050
Why?
Sequence Analysis, RNA
1
2024
96
0.050
Why?
PPAR gamma
1
2024
74
0.050
Why?
Integrin beta Chains
1
2023
14
0.050
Why?
Chromosomes, Human, Pair 13
1
2003
37
0.050
Why?
Integrins
1
2023
34
0.050
Why?
Receptors, Fibroblast Growth Factor
1
2002
8
0.050
Why?
Oxidative Phosphorylation
1
2023
48
0.050
Why?
Cytogenetic Analysis
1
2023
79
0.050
Why?
Chromosomes, Human, Pair 4
1
2002
30
0.050
Why?
Chromosomes, Human, Pair 14
1
2002
76
0.050
Why?
Chromosome Deletion
1
2023
138
0.050
Why?
Macrophage Activation
1
2022
22
0.050
Why?
Oncogene Proteins, Fusion
1
2002
62
0.050
Why?
Computational Biology
2
2020
209
0.050
Why?
Geography
1
2022
65
0.050
Why?
Porphyromonas gingivalis
1
2022
17
0.050
Why?
Chromatin
1
2023
145
0.050
Why?
Uterine Cervical Neoplasms
1
2005
301
0.040
Why?
Diploidy
3
2007
25
0.040
Why?
Inflammasomes
1
2022
66
0.040
Why?
DNA, Neoplasm
1
2002
146
0.040
Why?
Models, Animal
2
2015
233
0.040
Why?
Mutation Rate
1
2021
36
0.040
Why?
DNA Primers
2
2015
202
0.040
Why?
Proteins
1
2003
351
0.040
Why?
Clone Cells
1
2021
76
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.040
Why?
Genes, Tumor Suppressor
1
2021
73
0.040
Why?
Ovarian Neoplasms
1
2004
459
0.040
Why?
DNA Copy Number Variations
1
2021
117
0.040
Why?
Cytokines
3
2009
627
0.040
Why?
Double-Blind Method
2
2014
729
0.040
Why?
3' Untranslated Regions
1
2020
55
0.040
Why?
Wnt Signaling Pathway
1
2021
98
0.040
Why?
Immunohistochemistry
3
2009
975
0.040
Why?
DNA
1
2023
535
0.040
Why?
Software
1
2002
280
0.040
Why?
Gene Knockout Techniques
1
2019
50
0.040
Why?
Genetic Variation
1
2020
223
0.040
Why?
Drug Discovery
1
2020
94
0.040
Why?
Crystallography, X-Ray
1
2019
155
0.040
Why?
Mice, Nude
1
2019
232
0.040
Why?
Multivariate Analysis
1
2021
598
0.040
Why?
Protein Phosphatase 2
1
2019
4
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
180
0.040
Why?
G1 Phase
1
2019
13
0.040
Why?
Enzyme Activators
1
2019
8
0.040
Why?
Protein Conformation
1
2019
174
0.040
Why?
Structure-Activity Relationship
1
2020
396
0.040
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
12
0.040
Why?
Immunotherapy
1
2021
266
0.040
Why?
Active Transport, Cell Nucleus
1
2018
35
0.040
Why?
Wnt Proteins
2
2013
104
0.040
Why?
Calpain
1
2018
25
0.040
Why?
TOR Serine-Threonine Kinases
1
2019
83
0.040
Why?
Phosphorylation
1
2020
533
0.040
Why?
DNA Methylation
1
2023
592
0.040
Why?
Drug Resistance
1
2018
71
0.040
Why?
Autophagy
1
2020
199
0.030
Why?
Deferoxamine
1
2017
8
0.030
Why?
HT29 Cells
1
2017
13
0.030
Why?
Iron Chelating Agents
1
2017
12
0.030
Why?
Catalase
1
2017
72
0.030
Why?
Cell Cycle Checkpoints
1
2017
32
0.030
Why?
Chronic Disease
1
2019
580
0.030
Why?
Biological Transport
1
2016
150
0.030
Why?
Cell Hypoxia
1
2016
82
0.030
Why?
Models, Statistical
2
2008
229
0.030
Why?
Endoplasmic Reticulum Stress
1
2016
51
0.030
Why?
Drug Interactions
1
2016
196
0.030
Why?
Cell Line
2
2013
1016
0.030
Why?
Mice, Inbred ICR
1
2016
24
0.030
Why?
Microscopy, Electron, Transmission
1
2015
68
0.030
Why?
Transcriptional Activation
1
2016
128
0.030
Why?
Pharmacogenetics
2
2006
52
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
Vidarabine
1
2015
10
0.030
Why?
Mitoxantrone
1
2015
9
0.030
Why?
Sarcoplasmic Reticulum
1
2015
21
0.030
Why?
Myocardial Reperfusion
1
2015
13
0.030
Why?
Genes, Dominant
1
2015
22
0.030
Why?
Prostaglandin-Endoperoxide Synthases
1
2015
25
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2015
46
0.030
Why?
Diastole
1
2015
66
0.030
Why?
Vincristine
1
2015
89
0.030
Why?
Cytosol
1
2015
80
0.030
Why?
China
1
2015
135
0.030
Why?
Prednisone
1
2015
101
0.030
Why?
Cardiac Pacing, Artificial
1
2015
32
0.030
Why?
Ligands
1
2015
203
0.030
Why?
Microscopy, Fluorescence
1
2015
140
0.030
Why?
Vaccination
2
2007
310
0.030
Why?
Glutathione Peroxidase
1
2014
23
0.030
Why?
Cyclin B
1
2014
4
0.030
Why?
CDC2 Protein Kinase
1
2014
15
0.030
Why?
Molecular Targeted Therapy
1
2016
138
0.030
Why?
Disulfiram
1
2014
13
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Cyclophosphamide
1
2015
178
0.030
Why?
Membrane Potential, Mitochondrial
1
2014
44
0.030
Why?
Oxygen Consumption
1
2015
201
0.030
Why?
Chemotherapy, Adjuvant
1
2014
122
0.030
Why?
Antigens, Differentiation, T-Lymphocyte
1
2013
8
0.030
Why?
Lectins, C-Type
1
2013
30
0.030
Why?
Veratrum Alkaloids
1
2013
5
0.030
Why?
Multidrug Resistance-Associated Proteins
1
2013
17
0.030
Why?
Calcium
1
2015
373
0.030
Why?
Isoxazoles
1
2013
16
0.030
Why?
Glutathione
1
2014
303
0.030
Why?
Electrocardiography
1
2015
273
0.030
Why?
G1 Phase Cell Cycle Checkpoints
1
2013
18
0.030
Why?
Sulfones
1
2013
24
0.030
Why?
Gene Expression Regulation, Leukemic
1
2013
32
0.020
Why?
Hedgehog Proteins
1
2013
35
0.020
Why?
Itraconazole
1
2013
37
0.020
Why?
Peptide Library
1
2013
16
0.020
Why?
Receptors, Glucocorticoid
1
2013
34
0.020
Why?
Heart Ventricles
1
2015
260
0.020
Why?
Receptors, IgG
1
2013
23
0.020
Why?
Oxidants
1
2013
51
0.020
Why?
Azacitidine
1
2013
39
0.020
Why?
ADP-ribosyl Cyclase
2
2003
4
0.020
Why?
p38 Mitogen-Activated Protein Kinases
1
2013
92
0.020
Why?
Epitopes
1
2013
61
0.020
Why?
Hydrocortisone
1
2013
113
0.020
Why?
Blood Pressure
1
2015
518
0.020
Why?
Prospective Studies
2
2010
2411
0.020
Why?
MAP Kinase Signaling System
1
2013
127
0.020
Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
128
0.020
Why?
Histone Deacetylases
1
2013
59
0.020
Why?
Radiation, Ionizing
1
2013
101
0.020
Why?
Myocardium
1
2015
471
0.020
Why?
Osteoblasts
2
2006
480
0.020
Why?
Clinical Trials, Phase II as Topic
1
2012
48
0.020
Why?
Viper Venoms
1
2011
6
0.020
Why?
Protein C
1
2011
20
0.020
Why?
Risk
1
2011
306
0.020
Why?
Bone Density Conservation Agents
1
2010
75
0.020
Why?
Diphosphonates
1
2010
92
0.020
Why?
Databases as Topic
1
2009
38
0.020
Why?
Parathyroid Hormone
1
2010
149
0.020
Why?
Lymphocytes
1
2010
146
0.020
Why?
Cytoskeleton
1
2008
39
0.020
Why?
Genotype
1
2009
563
0.020
Why?
Twins
1
2007
21
0.020
Why?
STAT Transcription Factors
1
2007
8
0.020
Why?
Cytological Techniques
1
2007
13
0.020
Why?
NF-kappa B p52 Subunit
1
2007
6
0.020
Why?
NF-kappa B p50 Subunit
1
2007
17
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2009
238
0.020
Why?
I-kappa B Kinase
1
2007
20
0.020
Why?
Karyotyping
1
2007
77
0.020
Why?
HLA-A2 Antigen
1
2007
11
0.020
Why?
T-Lymphocytes, Cytotoxic
1
2007
67
0.020
Why?
Benzamides
1
2007
52
0.020
Why?
Antigen Presentation
1
2007
25
0.020
Why?
Remission Induction
1
2007
221
0.020
Why?
Polysaccharide-Lyases
1
2007
7
0.020
Why?
Leukocytes, Mononuclear
1
2007
122
0.020
Why?
Plasmids
1
2007
164
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2007
233
0.020
Why?
Enzyme Activation
1
2007
267
0.020
Why?
Tissue Culture Techniques
1
2007
42
0.020
Why?
Interferon-gamma
1
2007
174
0.020
Why?
Multigene Family
1
2006
50
0.020
Why?
Piperazines
1
2007
125
0.020
Why?
Neoplasms, Experimental
1
2007
112
0.020
Why?
Diagnosis, Differential
1
2010
1038
0.020
Why?
Anticoagulants
1
2009
280
0.020
Why?
Dendritic Cells
1
2007
133
0.020
Why?
Antineoplastic Agents, Hormonal
1
2006
56
0.020
Why?
Polymerase Chain Reaction
1
2007
452
0.020
Why?
Receptors, Estrogen
1
2007
134
0.020
Why?
Incidence
1
2009
1085
0.020
Why?
Gelatinases
1
2006
32
0.010
Why?
Chromosomes, Human
1
2006
41
0.010
Why?
Endopeptidases
1
2006
62
0.010
Why?
Rabbits
1
2006
372
0.010
Why?
Coculture Techniques
1
2006
146
0.010
Why?
Combined Modality Therapy
1
2007
640
0.010
Why?
Cyclin D3
1
2005
5
0.010
Why?
Cyclin D2
1
2005
21
0.010
Why?
Adipocytes
1
2006
131
0.010
Why?
Trisomy
1
2005
34
0.010
Why?
Oligonucleotide Probes
1
2004
18
0.010
Why?
Molecular Sequence Data
1
2006
759
0.010
Why?
Stem Cells
1
2006
189
0.010
Why?
Epithelium
1
2004
64
0.010
Why?
Ovary
1
2004
103
0.010
Why?
Endothelium, Vascular
1
2006
262
0.010
Why?
Bacterial Proteins
1
2007
347
0.010
Why?
Endothelial Cells
1
2006
289
0.010
Why?
Databases, Factual
1
2007
742
0.010
Why?
RNA, Complementary
1
2003
2
0.010
Why?
Autocrine Communication
1
2003
7
0.010
Why?
Paracrine Communication
1
2003
13
0.010
Why?
Metaphase
1
2003
47
0.010
Why?
Cell Separation
1
2003
76
0.010
Why?
Receptor, Fibroblast Growth Factor, Type 3
1
2002
18
0.010
Why?
Biopsy
1
2005
600
0.010
Why?
NAD+ Nucleosidase
1
2002
2
0.010
Why?
Melanoma-Specific Antigens
1
2002
3
0.010
Why?
Cell Communication
1
2003
73
0.010
Why?
Antigens, Differentiation
1
2002
16
0.010
Why?
Gene Expression Regulation, Developmental
1
2003
147
0.010
Why?
Cohort Studies
1
2006
1557
0.010
Why?
Immunoglobulins
1
2002
76
0.010
Why?
Database Management Systems
1
2002
27
0.010
Why?
Reproducibility of Results
1
2005
1219
0.010
Why?
Logistic Models
1
2003
947
0.010
Why?
Magnetic Resonance Imaging
1
2003
1583
0.010
Why?
Zhan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description